GlassScriptPhysician profile
Marina Kurian
NPI 1598824971
$328,038.79
in general payments reported to CMS, 2019-2025
31 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,707 · 2020: $42K · 2021: $16K · 2022: $43K · 2023: $71K · 2024: $104K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $134K · Consulting Fee: $64K · Food and Beverage: $12K · Travel and Lodging: $11K · Entertainment: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $134,480.81 |
| Consulting Fee | $64,290.65 |
| Food and Beverage | $11,554.97 |
| Travel and Lodging | $10,867.33 |
| Entertainment | $137.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $130,192.18 | 2019-2025 | Wegovy |
| Medtronic, INC. | $61,748.56 | 2021-2025 | Signia, Sonicision, Progrip |
| W. L. Gore & Associates, INC. | $34,862.45 | 2019-2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Allergan, INC. | $23,790.91 | 2020 | |
| Covidien LP | $20,558.36 | 2019-2020 | |
| Vivus LLC | $17,869.55 | 2019-2024 | Qsymia |
| Stryker Corporation | $17,033.31 | 2019-2025 | 1688, Aim (Advanced Imaging Modality), Spy-Phi System |
| Ethicon US, LLC | $10,349.25 | 2019-2024 | Echelon Endopath, Echelon Flex |
| Medical Device Business Services, INC. | $3,984.93 | 2023-2024 | Endopath Xcel, Harmonic, Echelon Circular |
| Heron Therapeutics, INC. | $2,326.31 | 2022 | |
| Apollo Endosurgery US INC | $1,191.41 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Reshape Lifesciences INC. | $1,137.82 | 2021-2023 | |
| Intuitive Surgical, INC. | $795.53 | 2021-2025 | Da Vinci Surgical System |
| Intra-Sana Laboratories | $418.84 | 2021-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Lilly USA, LLC | $297.67 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $224.49 | 2019-2024 | Contrave, Nexletol, Nexlizet |
| Merz North America, INC. | $150.55 | 2020 | |
| Davol INC. | $138.81 | 2019 | |
| Levita Magnetics International Corp | $132.97 | 2019 | |
| Integra Lifesciences Corporation | $129.42 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aesculap, INC. | $127.89 | 2019 | |
| Pfizer INC. | $125.00 | 2019 | |
| Tela Bio, INC. | $120.59 | 2024 | Ovitex 2s |
| Teleflex LLC | $65.76 | 2020-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Endo Pharmaceuticals INC. | $57.49 | 2019-2020 | |
| Ambu INC. | $55.60 | 2023 | |
| Olympus America INC. | $44.66 | 2019 | |
| Eisai INC. | $42.83 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $31.84 | 2019 | |
| Shire North American Group INC | $19.50 | 2019 | |
| Innocoll Pharmaceuticals Limited | $14.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Kurian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.